Alvac poxvirus-rabies compositions and combination compositions and uses
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 1, 1998
Issued Date -
N/A
app pub date -
Jun 7, 1995
filing date -
Mar 7, 1991
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Attenuated recombinant viruses containing DNA encoding a rabies virus antigen in a 'cocktail' or combination or multivalent compositions well as methods for making and using the compositions, expression products therefrom, and antibodies generated, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The compositions and products therefrom and antibodies generated have several preventive, therapeutic and diagnostic uses.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully